Tell your doctor your entire medical history including any eye surgery, allergies, (especially allergies to ganciclovir or acyclovir), other infections you may have or any blood disorders.

Although the drug contained in this implant is released in small doses be aware there are no studies to date on the effects of this drug on pregnant women.

Therefore this device should be used during pregnancy only if clearly needed.

Consult with your doctor.

It is not known if the drug in this implant is excreted into breast milk.

However, due to animal studies using other forms of this drug and because many drugs are excreted into breast milk, it is suggested that mothers stop breast-feeding while this implant is used.

Consult with your doctor.

Generic Name: ANCICLOVIR - INTRAVITREAL IMPLANT

Vitrasert 4.5 mg Implant - Prescription

Cytovene 250 mg Capsule - Prescription

Cytovene 500 mg Capsule - Prescription

EMM035-06-07

http://www.e-emm.org/article/article_files/EMM035-06-07.pdf

mice, BAT, GCV, adipocytes, UCP1, brown, cells, gene, adipose tissue, white adipocytes, periphery, apoptosis, uncoupling protein, transgene.

As a genetic tissue ablation model of BAT, we made transgenic mice expressing herpes simplex virus thymidine kinase (HSV-TK) driven by the brown adipocytespecific UCP1 minimal regulatory element.

The HSV-TK transgene was expressed specifically in BAT and more than 35% increase of apoptosis was induced by ganciclovir (GCV) treatment.

Both inner multilocular and peripheral unilocular adipocytes were UCP-positive in all groups, whereas only unilocular adipocytes in BAT of the GCV-treated UCP-TK mouse were leptin-positive.

Relative intensity of leptin signal in the peripheral BAT was calculated after measuring the intensity of signal in more than 100 brown adipocytes for each sample using Image-Pro Plus program (Media Cybernetics).

2004-HazDrugAlert

drugs, exposure, contamination, safety, healthcare, pharmacy, workers, handling, employment, agents, protection, personnel, hazards, hazardous drugs.

Healthcare workers who prepare or administer hazardous drugs or who work in areas where these drugs are used may be exposed to these agents in air or on work surfaces, contaminated clothing, medical equipment, patient excreta, or other sources.

The health risk is influenced by the extent of the exposure and the potency and toxicity of the hazardous drug.

single biological marker has been found to be a good indicator of exposure to hazardous drugs or a good predictor of subsequent adverse health effects onnor.

The following case reports illustrate the range of health effects exhibited after exposure to antineoplastic drugs.

chapter13

http://www.crab.org/CRAmanual/Vol2/chapter13.pdf

patients, disease, bone marrow, treatment, immunoglobulin, biopsy, protein, diagnosis, urine, light chain, pre-treatment, cells, serum, M-component.

This disease site includes the following three malignancies: multiple myeloma, amyloidosis, and waldenstrom's macroglobulinemia.

Presenting symptoms may include bone pain due to osteolytic lesions, resulting from abnormal plasma cells proliferating and accumulating in the bone marrow; weakness; and fatigue.

SWOG Patient No. SWOG Study No. Patient's Name

A plasmacytoma is an accumulation of plasma cell tumors located outside the bone marrow.

No Yes If Yes, Date of treatment initiation Treatment description Did acute GVHD improve?

Disease Status of Patient Receiving Stem Cell Support: Indicate the patient's appropriate disease status according to the following definitions.

Please refer to Patient Characteristics in Chapter 1 of Volume II.